Irritable Bladder Syndrome (IBS) Is a Part of Functional Bowel Syndrome (FBS): A Randomized Open Label Prospective Clinical Trial

被引：0
|
作者：
Basu, P. Patrick [1 ]
Nair, Thankam [2 ]
Shah, Niraj James [2 ]
Farhat, Sakina [2 ]
机构：
[1] Columbia Univ Coll Phys & Surg, Forest Hills, NY USA
[2] Northshore Forest Hills Hosp, Forest Hills, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2011年 / 106卷
关键词：
D O I：
10.14309/00000434-201110002-01336
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1336
引用
收藏
页码：S511 / S512
页数：2
相关论文
共 50 条
  • [41] Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial
    Ricci, Chiara
    Rizzello, Fernando
    Valerii, Maria Chiara
    Spisni, Enzo
    Gionchetti, Paolo
    Turroni, Silvia
    Candela, Marco
    D'Amico, Federica
    Spigarelli, Renato
    Bellocchio, Irene
    Marasco, Giovanni
    Barbara, Giovanni
    NUTRIENTS, 2022, 14 (19)
  • [42] NONCARDIAC CHEST PAIN (NCCP) AND IRRITABLE-BOWEL-SYNDROME (IBS) - PART OF A CONTINUUM
    MCMAHON, TP
    RICHTER, JE
    GASTROENTEROLOGY, 1986, 90 (05) : 1546 - 1546
  • [43] An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder
    Kaplan, Alicia
    Franzen, Michael D.
    Nickell, P. V.
    Ransom, Danielle
    Lebovitz, Paul J.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2014, 18 (01) : 11 - 15
  • [44] An Open-Label Trial Study of Quality-of-Life Assessment in Irritable Bowel Syndrome and Their Treatment
    Alexandru, Bogdana Ariana
    Rat, Lavinia Alina
    Moldovan, Andrada Florina
    Mihancea, Petru
    Maris, Lavinia
    MEDICINA-LITHUANIA, 2022, 58 (06):
  • [45] An open label study to determine the efficacy and tolerability of tegaserod in the treatment of constipation dominant irritable bowel syndrome (IBS-C)
    Shah, HA
    Jafri, W
    Butt, JA
    Mohsin, A
    Khan, I
    GASTROENTEROLOGY, 2003, 124 (04) : A533 - A533
  • [46] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
    Ballou, Sarah
    Kaptchuk, Ted J.
    Hirsch, William
    Nee, Judy
    Iturrino, Johanna
    Hall, Kathryn T.
    Kelley, John M.
    Cheng, Vivian
    Kirsch, Irving
    Jacobson, Eric
    Conboy, Lisa
    Lembo, Anthony
    Davis, Roger B.
    TRIALS, 2017, 18
  • [47] Psychological Predictors of Response to Open-Label Versus Double-Blind Placebo in a Randomized Controlled Trial in Irritable Bowel Syndrome
    Ballou, Sarah
    Haas, Julia W.
    Iturrino, Johanna
    Nee, Judy
    Kirsch, Irving
    Rangan, Vikram
    Cheng, Vivian
    Lembo, Anthony
    Kaptchuk, Ted J.
    Kelley, John M.
    PSYCHOSOMATIC MEDICINE, 2022, 84 (06): : 738 - 746
  • [48] Meditation and yoga for irritable bowel syndrome: study protocol for a randomised clinical trial (MY-IBS study)
    D'Silva, Adrijana
    Marshall, Deborah A.
    Vallance, Jeffrey
    Nasser, Yasmin
    Rajagopalan, Vidya
    MacKean, Gail
    Raman, Maitreyi
    BMJ OPEN, 2022, 12 (05):
  • [49] Frequent Overlap of Overactive Bladder with Functional Dyspepsia and/or Irritable Bowel Syndrome
    Suzuki, Hidekazu
    Matsuzaki, Juntaro
    Asakura, Keiko
    Fukushima, Yasushi
    Okada, Sawako
    Takebayashi, Toru
    Hibi, Toshifumi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S510 - S510
  • [50] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
    Sarah Ballou
    Ted J. Kaptchuk
    William Hirsch
    Judy Nee
    Johanna Iturrino
    Kathryn T. Hall
    John M. Kelley
    Vivian Cheng
    Irving Kirsch
    Eric Jacobson
    Lisa Conboy
    Anthony Lembo
    Roger B. Davis
    Trials, 18
12345